Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy

BACKGROUND: Glioblastoma is the most lethal primary brain malignancy in adults. Standard of care treatment, consisting of temozolomide (TMZ) and adjuvant radiotherapy (RT), mostly does not prevent local recurrence. The inability of drugs to enter the brain, in particular antibody-based drugs and rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Gal, Omer, Betzer, Oshra, Rousso-Noori, Liat, Sadan, Tamar, Motiei, Menachem, Nikitin, Maxim, Friedmann-Morvinski, Dinorah, Popovtzer, Rachela, Popovtzer, Aron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613745/
https://www.ncbi.nlm.nih.gov/pubmed/36324626
http://dx.doi.org/10.3390/jnt3040012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613745/
https://www.ncbi.nlm.nih.gov/pubmed/36324626
http://dx.doi.org/10.3390/jnt3040012

Ejemplares similares